The heparan sulphate proteoglycan Syndecan‐1 ( <scp>CD138</scp> ) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breast-Reference-Cited by-同舟云学术

The heparan sulphate proteoglycan Syndecan‐1 ( CD138 ) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breast

Published:2022-05-19 Issue:10 Volume:74 Page:955-968
ISSN:1521-6543
Container-title:IUBMB Life
language:en
Short-container-title:IUBMB Life

Author:

D'Arcy Christopher¹,Zimmermann Clarissa Constanze¹,Espinoza‐Sanchez Nancy Adriana¹²^ORCID,Greve Burkhard²,Schmidt Annika¹,Kiesel Ludwig¹,von Wahlde Marie‐Kristin¹,Götte Martin¹^ORCID

Affiliation:

1. Department of Gynecology and Obstetrics Münster University Hospital Münster Germany

2. Department of Radiotherapy‐Radiooncology, Department of Radiotherapy and Radiooncology University Hospital Münster Münster Germany

Funder

Deutsche Forschungsgemeinschaft

Medical Faculty Münster

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Genetics,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iub.2623

Reference48 articles.

1. Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer

2. Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast

3. Ductal carcinoma in situ: to treat or not to treat, that is the question

4. Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study

5. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targets in the Tumour Matrisome to Promote Cancer Therapy Response;Cancers;2024-05-11

2. Downregulation of RNA binding protein 47 predicts low survival in patients and promotes the development of renal cell malignancies through RNA stability modification;Molecular Biomedicine;2023-11-14

3. Syndecan-1: A Novel Diagnostic and Therapeutic Target in Liver Diseases;Current Drug Targets;2023-11

4. Recent progress on the effect of extracellular matrix on occurrence and progression of breast cancer;Life Sciences;2023-11

5. Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma;Cancers;2023-03-16